ABOUT US PORTFOLIO COMPANIES INVESTORS PRESS CONTACT Portfolio Companies Headquartered in Memphis, TN, CrossRoads was founded in 2014 by Glen Coleman, Vernon Hartdegen and Chad Hollis. The Company's mission is to develop and commercialize innovative technologies in the orthopedic extremity sector that improve the operating room experience and patient outcomes through simplicity and accuracy for the surgeon, and sustainability and cost reduction for healthcare institutions. CrossRoads' Active Stabilization® technology is the only technology on the market today to simultaneously offer enhanced stability with continuous compression, optimizing conditions for bone healing in fusion procedures. The Company leverages this technology in a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for both lower and upper extremity indications. The Company's EcoSMART® Instrument Service provides customers with gamma sterilized, reusable instruments for every surgical case and post-surgery recovery and processing of those instruments. EcoSMART® reduces the inefficiencies of traditional non-sterile instrument trays and eliminates the waste associated with typical disposable instruments. IlluminOss Medical is a privately held, commercial stage medical device company focused on designing, developing, and marketing orthopedic fracture repair and stabilization products that leverage its proprietary system. The IlluminOss system is a minimally invasive technology that allows for fracture repair and stabilization through the formation of a patient specific intramedullary implant. Specifically designed for the repair and treatment of poor quality, compromised bone; eg osteoporotic or pathologic. The IlluminOss system utilizes a light curable polymer contained within an expandable balloon catheter to create a patient conforming intramedullary implant for bone stabilization. The revolutionary procedure is made through a small minimally invasive surgical approach, providing patients and clinicians with a fast, patient specific method of orthopedic bone stabilization. The Company currently markets its products in the EU under a CE mark and in the USA under FDA clearance. Founded in 2007, IlluminOss is headquartered in East Providence, RI. Blue Belt Technologies (“Blue Belt”) is one of three orthopedic surgical robotics companies. Its core product allows the general orthopedist to perform joint replacement procedures with consistency and confidence. The company has proprietary robotic technology and tools for use in minimally invasive computer-assisted orthopedic, neurosurgical, craniomaxillofacial (CMF) and ear, nose and throat (ENT) procedures. Blue Belt represents a key beachhead in the development of Fund III’s continuum of care strategy and is particularly focused on the knee and hip markets. ProSomnus® Sleep Technologies designs, manufactures and markets FDA Cleared Class II Medical Devices dentists use to treat patients diagnosed with Obstructive Sleep Apnea. ProSomnus Devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects and, enable dentists to achieve excellent patient experiences and outcomes. They have been used to treat thousands of patients, with clinical performance that has been validated in randomized controlled trials, retrospective cohort studies, and numerous clinical case reports. China Rehabilitation, Ltd. (formerly ChinaRehab now renamed “SinoRehab”) is a company formed in Beijing, China that will provide post-operative, outpatient orthopedic rehabilitation services to private pay patients who have recently undergone orthopedic surgical interventions. The pilot rehabilitation facility has now been located adjacent to Beijing’s leading orthopedic hospital, Ji Shui Tan (“JST”). The business plan is to roll out a chain of branded for-profit outpatient facilities starting in Beijing and expanding to other major cities. Alphatec Spine, Inc. (NASDAQ: ATEC) is a medical technology company focused on the design, development and marketing of products for the treatment of spine disorders. The Company develops products and systems that seek to address the entire spinal fusion procedure in the most effective and efficient way possible. The product design focus is on simplifying procedures for the surgeon with the ultimate objective of improving patient outcomes. BioHorizons, Inc. is a medical technology company focused on developing, manufacturing and marketing a broad line of innovative, proprietary and evidence-based dental implants, as well as hard and soft tissue regeneration products, for the replacement of missing teeth. The company has designed its dental implant product portfolio to address the clinical requirements in implant dentistry. The company is the sixth-largest dental implant company in the North American market and has been growing faster than the market due to its patented technology, successful new product launches and customer service. BioHorizons has 321 employees worldwide. OrthoSpace Ltd. is a privately held company located in Caesarea, Israel, that offers disruptive technology for the treatment of severe rotator cuff (“RC”) tears, a large market segment with limited treatment options and little historic innovation. InSpace, OrthoSpace’s flagship product, is an orthopedic biodegradable balloon system. The InSpace procedure is a simple, safe and minimally invasive method that addresses an unmet clinical need. HealthpointCapital sold OrthoSpace Ltd. to Stryker in March 2019. OrthoAccel is a medical device company located in Houston, Texas that has now established its position as “first mover” in the emerging discipline of accelerated orthodontics. The company’s principal product is the AcceleDentTM. Nexa Orthopedics, Inc. was founded in 2004 by HealthpointCapital to create the pre-eminent company in extremities surgery through a program of business investments, technology in-licensing, internal development, and acquisition. The investment opportunity in the highly fragmented market was based on consolidation and scale and driven by differentiated technology. In February 2005, Nexa acquired Futura Biomedical, LLC. Futura manufactured and distributed the only complete line of forefoot arthroplasty products and was a leading innovator of implants for the correction of flexible flatfood deformities. In the summer of 2005, Nexa acquired the StayFuse product line from Pioneer Surgical. Nexa also partners with OsteoBiologics, Inc. for U.S. distribution of OBI products in hand, foot and ankle surgery. In November 2005, Nexa acquired BioProfile S.S, a French manufacturer of orthopedic extremity products utilizing its novel pryocarbon. In September 2006, Nexa acquired Axiom Orthopaedics, Inc., a leading innovator in the shoulder arthroplasty market. HealthpointCapital sold Nexa Orthopedics, Inc. to Tornier in February 2007. The sale of Nexa provided HeathpointCapital Partners, L.P. a 75% internal rate of return on its investment. HOME ABOUT US Mission & Vision Management Board Of Advisors Values Focused Experience Our Research PORTFOLIO COMPANIES INVESTORS Fund I, II, And III Investor Login Fund IV Investor Login ESG Investing Impact CONTACT 505 Park Avenue 17th Floor New York, NY 10022 Tel: 212-935-7780 Fax: 212-935-6878 Disclosure Policy | © 2021 HealthpointCapital